Semmelweis University

At Semmelweis University, the clinical trial portfolio includes research in immune system diseases and musculoskeletal diseases, with a strong focus on childhood inflammatory conditions. Studies here are mainly aimed at evaluating new treatment options, understanding safety, and improving outcomes for young patients with chronic autoimmune disorders.

• Polyarticular course juvenile idiopathic arthritis and related pediatric rheumatic disease
• Osteogenesis imperfecta and other childhood bone disorders
• Assessment of treatment effectiveness and long-term safety in pediatric inflammatory disease

This work reflects the site’s specialization in pediatric rheumatology and immunology, supporting better care for children with complex, long-term conditions.

Clinical research at this Budapest site also covers neoplasms, especially aggressive blood cancers in infants and children. The studies are designed to improve survival, refine treatment strategies, and generate better evidence for managing rare pediatric malignancies.

• Acute lymphoblastic leukemia in infants
• Evaluation of treatment effectiveness against high-risk childhood leukemia
• Research focused on improving long-term outcomes in rare pediatric cancer

These trials contribute to advancing care for children with serious hematologic cancers through more effective and better-tolerated therapy approaches.

The site conducts trials in bacterial infections and virus diseases, with an emphasis on serious infections affecting children. Research in this area is centered on testing new anti-infective therapies, assessing safety, and supporting more effective treatment for difficult-to-manage infections.

• Blood stream infection, sepsis, and complicated bacterial infections
• Urinary tract infection, intra-abdominal infection, and pneumonia
• COVID-19 and pediatric antiviral therapy research

These studies help address both common and severe infectious diseases, including hospital-related and resistant bacterial infections in children.

Another important area of investigation is respiratory tract disease, particularly childhood asthma and wheezing disorders. Trials at the site aim to evaluate new therapies that may reduce symptoms, prevent flare-ups, and improve day-to-day breathing control in young patients.

• Asthma and recurrent asthmatic wheeze
• Improving control of severe respiratory symptoms in young children
• Testing treatment effectiveness and tolerability in pediatric airway disease

This research supports better management of chronic respiratory conditions during early childhood.

Clinical trials at Semmelweis University also extend to nutritional and metabolic diseases, including pediatric diabetes care. The main goal is to explore whether new treatment approaches can improve metabolic control while maintaining safety in children and adolescents.

• Type 2 diabetes mellitus
• Evaluation of glucose control and treatment tolerability
• Support for better long-term management of metabolic disease in youth

These studies add to the understanding of how emerging therapies may fit into pediatric diabetes care.

Research in analytical, diagnostic and therapeutic techniques and equipment includes pediatric imaging studies, with an emphasis on improving the use of contrast-enhanced magnetic resonance imaging. The purpose is to better understand how diagnostic tools behave in children and to support safer, more effective imaging practice.

• Contrast enhancement in magnetic resonance imaging in children
• Evaluation of diagnostic performance and safety in pediatric imaging
• Support for more reliable imaging-based assessment of disease

This area helps strengthen diagnostic care for children who need advanced imaging during clinical evaluation.